RCAT is trading at $9.37 (+5.18%) after investors rejected the company’s advisory executive compensation proposal at its June 18 annual meeting.
- Shareholders pushed back on the executive pay packages, citing significant concerns regarding potential share dilution and governance.
- The stock-specific news is serving as a clear catalyst for the price action, even as the broader technology sector faces market weakness today.